Literature DB >> 17123516

Development of immortalized rat conjunctival epithelial cell lines: an in vitro model to examine transepithelial antigen delivery.

Nancy L O'Sullivan1, Alfred E Baylor, Paul C Montgomery.   

Abstract

The objective of these studies was to develop conjunctival epithelial cell lines for investigation of antigen translocation across a mucosal barrier. Conjunctival epithelial cells from Fischer 344 rats were immortalized with pSV3(neo) resulting in two cell lines--CJ4.1A and CJ4.3C. Each formed confluent cell layers with epithelial morphology when grown on permeable membrane filters. They expressed the SV40 T antigen, the conjunctiva-specific cytokeratin 4, the goblet cell-specific cytokeratin 7 and were negative for the corneal epithelial cell-specific cytokeratin 12. The cell lines have been in culture for over 60 passages, and the population doubling times were 22+/-7h for CJ4.1A and 23+/-9h for CJ4.3C. When grown on Transwell membranes, each cell line achieved a transepithelial electrical resistance of 600-800 Omega cm2 by 3-4 days and maintained a high resistance for several days. Both cell lines expressed zona occludens-1 at confluence. At 24h following addition of 250 microg of FITC-labeled ovalbumin to the apical chambers, 15+/-6 microg could be detected in the basal chamber of CJ4.1A and 6+/-1 microg in the basal medium of CJ4.3C. In contrast, 82+/-6 microg was detected in the lower chambers of cell-free Transwells. Similarly, Transwells containing confluent CJ4.1A or CJ4.3C cells impeded passage of 0.1 microm diameter polystyrene microspheres (5+/-1% and 4+/-1%, respectively, of the apical input), compared to 26+/-6% of the input microspheres recovered from the basal chambers of cell-free Transwells. Pretreatment with 4mM EGTA for 10 min caused an increase in OVA-FITC translocation across CJ4.3C cells. Incubation in the presence of 4mM EGTA significantly increased OVA-FITC translocation across both cell lines, relative to untreated cell layers. Morphological and functional characterization indicates that these cells provide a useful experimental tool to assess strategies for enhancing transepithelial antigen uptake.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123516      PMCID: PMC1839946          DOI: 10.1016/j.exer.2006.10.005

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  29 in total

1.  In vivo behavior of peptide-specific T cells during mucosal tolerance induction: antigen introduced through the mucosa of the conjunctiva elicits prolonged antigen-specific T cell priming followed by anergy.

Authors:  R M Egan; C Yorkey; R Black; W K Loh; J L Stevens; E Storozynsky; E M Lord; J G Frelinger; J G Woodward
Journal:  J Immunol       Date:  2000-05-01       Impact factor: 5.422

2.  Isolation and maintenance of differentiated exocrine gland acinar cells in vitro.

Authors:  C Oliver
Journal:  In Vitro       Date:  1980-04

3.  Pseudomonas aeruginosa corneal infection affects cholinergic enzymes in rat lacrimal gland.

Authors:  K H Dannelly; Y Liu; S K Ghosh
Journal:  Arch Microbiol       Date:  2001-10-30       Impact factor: 2.552

4.  Effects of T-lymphocyte-dependent and -independent immunity on cholinergic enzyme activity in mouse lacrimal gland.

Authors:  K Sinha; H K Dannelly; S K Ghosh
Journal:  Exp Physiol       Date:  2001-03       Impact factor: 2.969

5.  Isolation, characterization, and propagation of rat conjunctival goblet cells in vitro.

Authors:  M A Shatos; J D Rios; V Tepavcevic; H Kano; R Hodges; D A Dartt
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

6.  Initiation and characterization of keratinocyte cultures from biopsies of normal human conjunctiva.

Authors:  Barbara C Risse Marsh; Mina Massaro-Giordano; Christine M Marshall; Robert M Lavker; Pamela J Jensen
Journal:  Exp Eye Res       Date:  2002-01       Impact factor: 3.467

7.  Evidence for differential signaling in human conjunctival epithelial cells adherent to laminin isoforms.

Authors:  L Lin; C Daneshvar; M Kurpakus-Wheater
Journal:  Exp Eye Res       Date:  2000-04       Impact factor: 3.467

8.  Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva.

Authors:  Yolanda Diebold; Margarita Calonge; Amalia Enríquez de Salamanca; Amalia Enríquez de Salamanca; Sagrario Callejo; Rosa M Corrales; Victoria Sáez; Karyn F Siemasko; Michael E Stern
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-10       Impact factor: 4.799

9.  Development of a conjunctival epithelial equivalent with improved proliferative properties using a multistep serum-free culture system.

Authors:  Leonard P K Ang; Donald T H Tan; Roger W Beuerman; Robert M Lavker
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-06       Impact factor: 4.799

Review 10.  Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation.

Authors:  B N Lambrecht
Journal:  Respir Res       Date:  2001-04-19
View more
  4 in total

Review 1.  TEER measurement techniques for in vitro barrier model systems.

Authors:  Balaji Srinivasan; Aditya Reddy Kolli; Mandy Brigitte Esch; Hasan Erbil Abaci; Michael L Shuler; James J Hickman
Journal:  J Lab Autom       Date:  2015-01-13

2.  Ocular Drug Delivery; Impact of in vitro Cell Culture Models.

Authors:  Jaleh Barar; Masoud Asadi; Seyed Abdolreza Mortazavi-Tabatabaei; Yadollah Omidi
Journal:  J Ophthalmic Vis Res       Date:  2009-10

3.  Expression patterns of conjunctival mucin 5AC and aquaporin 5 in response to acute dry eye stress.

Authors:  Dhruva Bhattacharya; Li Yu; Mingwu Wang
Journal:  PLoS One       Date:  2017-11-07       Impact factor: 3.240

4.  Characterization of doxycycline-dependent inducible Simian Virus 40 large T antigen immortalized human conjunctival epithelial cell line.

Authors:  Arisa Mitani; Takeshi Kobayashi; Yasuhito Hayashi; Natsuki Matsushita; Sachi Matsushita; Saori Nakao; Naoko Takahira; Atsushi Shiraishi; Yuichi Ohashi
Journal:  PLoS One       Date:  2019-09-11       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.